Relevant aspects of coronary artery disease in candidates for non-cardiac surgery

Gilson Cassem Ramos1

  • 1Cardiology Department of Hospital Samaritano de Goiânia/GO, Brazil. gilson.ramos@terra.com.br

Insights

Patients with coronary artery disease (CAD) undergoing surgery need careful preoperative evaluation. High-risk individuals may benefit from ischemia tests, interventions, beta-blockers, and statins to reduce complications.

Area of Science:

  • Cardiology
  • Perioperative Medicine
  • Surgical Risk Assessment

Background:

  • Coronary artery disease (CAD) is a leading cause of morbidity and mortality in patients undergoing elective surgeries.
  • Understanding CAD's characteristics and physiopathogenic mechanisms is crucial for preoperative management.
  • Identifying patients at greater surgical risk is essential for targeted interventions.

Purpose of the Study:

  • To review and establish preoperative guidelines for patients with coronary artery disease (CAD) undergoing non-cardiac surgery.
  • To minimize perioperative and postoperative morbidity and mortality in this patient population.

Main Methods:

  • Review of existing rules and directives for preoperative care in patients with CAD.
  • Analysis of variables related to preoperative management.
  • Evaluation of conduct for high-risk surgical patients.

Main Results:

  • Judicious evaluation is necessary for all CAD patients undergoing non-cardiac surgery.
  • High-risk patients can benefit from preoperative myocardial ischemia-provoking tests.
  • Invasive coronary interventions prior to elective surgery may be beneficial for selected patients.

Conclusions:

  • Preoperative assessment and risk stratification are critical for patients with CAD undergoing non-cardiac surgery.
  • Consideration of beta-blockers and statins is recommended for selected high-risk patients.
  • Proactive management, including ischemia testing and interventions, can improve outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...